Coartem Articles
Novartis' Coartem approved by FDA
9 April 2009
Uganda Minister fear for local ACT drug jobs
2 March 2009
Coartem Disp debuts in Africa
23 February 2009
Novartis launches Coartem Dispersible
9 February 2009
Novartis
8 November 2008
FDA Fast-Track voucher system faces test
27 October 2008
Novartis' FDA priority review for Coartem
22 September 2008
Novartis cuts price of malaria drug Coartem 20%
28 April 2008
US think-tank warning over new malaria drugs
17 September 2007
Novartis to improve malaria drug access
9 October 2006
GSK initiates Ph III trial for new malaria drugs
31 July 2006
Kenya's pharma says: "No new malaria drug"
8 May 2006
Kenya bans sulphur-based malaria drugs
1 May 2006
Novartis reports strong Ph III results for SPP100
30 January 2006
Novartis offers malria drug in Africa grants
28 April 2005
Novartis and MMV to develop pediatric Coartem
17 November 2003
WHO "essential list" of malaria, AIDS drugs
6 May 2002
Novartis launches new antimalarial in Europe
31 May 2001
Novartis/WHO sign malaria drug deal
28 May 2001
Showing 1-26 of 26 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
